Hemoglobin level at initiation of darbepoetin alfa: impact on need for transfusion and associated costs in chemotherapy-induced anemia treatment in Europe

被引：0
作者：
Melike Deger
Wolfgang Eisterer
Lucie Kutikova
Sam Salek
机构：
[1] Cardiff University,Welsh School of Pharmacy
[2] Amgen Europe GmbH,Department for Internal Medicine I
[3] Medical University Innsbruck,Centre for Socioeconomic Research, Welsh School of Pharmacy
[4] Cardiff University,undefined
来源：
Supportive Care in Cancer | 2013年 / 21卷
关键词：
Costs; Darbepoetin alfa; Erythropoiesis-stimulating agents; Hemoglobin; Transfusion;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：485 / 493
页数：8
相关论文
共 40 条
  • [31] Epoetin alfa and darbepoetin alfa for the treatment of chemotherapy-related anemia in cancer patients in Sweden: Comparative analysis of drug utilization, costs, and hematologic response
    Persson, U
    Borg, S
    Jansson, S
    Ekman, T
    Franksson, L
    Friesland, S
    Larsson, AM
    [J]. ADVANCES IN THERAPY, 2005, 22 (03) : 208 - 224
  • [32] Randomized, double-blind, placebo-controlled trial of every-3-week darbepoetin alfa 300 micrograms for treatment of chemotherapy-induced anemia
    Hernandez, Enrique
    Ganly, Peter
    Charu, Veena
    DiBenedetto, Joseph
    Tomita, Dianne
    Lillie, Tom
    Taylor, Kerry
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2009, 25 (09) : 2109 - 2120
  • [33] A Randomized, Double-Blind, Placebo-Controlled, Phase III Noninferiority Study of the Long-Term Safety and Efficacy of Darbepoetin Alfa for Chemotherapy-Induced Anemia in Patients With Advanced NSCLC
    Gascon, Pere
    Nagarkar, Rajnish
    Smakal, Martin
    Syrigos, Konstantinos N.
    Barrios, Carlos H.
    Cardenas Sanchez, Jesus
    Zhang, Li
    Henry, David H.
    Gordon, David
    Hirsh, Vera
    Kubota, Kaoru
    Orlov, Sergey
    Thomas, Gary
    Steinmetz, Tilman
    Kang, Jin-Hyoung
    Tomita, Dianne K.
    Fleishman, Alexander N.
    Park, Joseph K.
    Brandao, Cisio De Oliveira
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2020, 15 (02) : 190 - 202
  • [34] Assessing the effect of darbepoetin alfa on patient-reported fatigue in chemotherapy-induced anemia in four randomized, placebo-controlled clinical trials
    Dennis A. Revicki
    Donald Stull
    Margaret Vernon
    Michael Rader
    Dianne Tomita
    Hema N. Viswanathan
    [J]. Quality of Life Research, 2012, 21 : 311 - 321
  • [35] Routine once-weekly darbepoetin alfa administration is cost-effective in lung cancer patients with chemotherapy-induced anemia: A Markov analysis
    Borget, I
    Tilleul, P
    Baud, M
    Joly, AC
    Daguenel, A
    Chouaid, C
    [J]. LUNG CANCER, 2006, 51 (03) : 369 - 376
  • [36] Darbepoetin alfa for treating chemotherapy-induced anemia in patients with a baseline hemoglobin level < 10 g/dL versus ≥10 g/dL: an exploratory analysis from a randomized, double-blind, active-controlled trial
    Johan Vansteenkiste
    Michael Hedenus
    Pere Gascon
    Carsten Bokemeyer
    Heinz Ludwig
    Jan Vermorken
    Lisa Hamilton
    Ken Bridges
    Beatriz Pujol
    [J]. BMC Cancer, 9
  • [37] Meta-analysis of epoetin beta and darbepoetin alfa treatment for chemotherapy-induced anemia and mortality: Individual patient data from Japanese randomized, placebo-controlled trials
    Ohashi, Yasuo
    Uemura, Yukari
    Fujisaka, Yasuhito
    Sugiyama, Toru
    Ohmatsu, Hironobu
    Katsumata, Noriyuki
    Okamoto, Rumiko
    Saijo, Nagahiro
    Hotta, Tomomitsu
    [J]. CANCER SCIENCE, 2013, 104 (04) : 481 - 485
  • [38] Effectiveness of darbepoetin alfa in a cohort of oncology patients with chemotherapy-induced anaemia. Relationship between variation in three fatigue-specific quality of life questionnaire scores and change in haemoglobin level
    Gaspar Esquerdo
    Cristina Llorca
    José Manuel Cervera
    David Orts
    Asunción Juárez
    Alfredo Carrato
    [J]. Clinical and Translational Oncology, 2011, 13 : 341 - 347
  • [39] Effectiveness of darbepoetin alfa in a cohort of oncology patients with chemotherapy-induced anaemia. Relationship between variation in three fatigue-specific quality of life questionnaire scores and change in haemoglobin level
    Esquerdo, Gaspar
    Llorca, Cristina
    Manuel Cervera, Jose
    Orts, David
    Juarez, Asuncion
    Carrato, Alfredo
    [J]. CLINICAL & TRANSLATIONAL ONCOLOGY, 2011, 13 (05) : 341 - 347
  • [40] Potential Health Economic Impact of Intravenous Iron Supplementation to Erythropoiesis-Stimulating Agent Treatment in Patients with Cancer- or Chemotherapy-Induced Anemia
    Szucs, T. D.
    Blank, P. R.
    Schwenkglenks, M.
    Aapro, M.
    [J]. ONCOLOGY, 2011, 81 (01) : 45 - 49
1234